IL173835A0 - Compositions useful for treating gastrointestinal motility disorders - Google Patents
Compositions useful for treating gastrointestinal motility disordersInfo
- Publication number
- IL173835A0 IL173835A0 IL173835A IL17383506A IL173835A0 IL 173835 A0 IL173835 A0 IL 173835A0 IL 173835 A IL173835 A IL 173835A IL 17383506 A IL17383506 A IL 17383506A IL 173835 A0 IL173835 A0 IL 173835A0
- Authority
- IL
- Israel
- Prior art keywords
- compositions useful
- gastrointestinal motility
- motility disorders
- treating gastrointestinal
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49920003P | 2003-08-29 | 2003-08-29 | |
| US59823504P | 2004-08-03 | 2004-08-03 | |
| PCT/US2004/028115 WO2005021040A2 (en) | 2003-08-29 | 2004-08-27 | Compositions useful for treating gastrointestinal motility disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL173835A0 true IL173835A0 (en) | 2006-07-05 |
Family
ID=34278649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL173835A IL173835A0 (en) | 2003-08-29 | 2006-02-20 | Compositions useful for treating gastrointestinal motility disorders |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20050059704A1 (https=) |
| EP (1) | EP1663313A2 (https=) |
| JP (1) | JP2007507425A (https=) |
| KR (1) | KR20060118421A (https=) |
| AU (2) | AU2004268641A1 (https=) |
| BR (1) | BRPI0414046A (https=) |
| CA (1) | CA2537182A1 (https=) |
| IL (1) | IL173835A0 (https=) |
| MX (1) | MXPA06002139A (https=) |
| WO (1) | WO2005021040A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060118421A (ko) * | 2003-08-29 | 2006-11-23 | 다이노젠 파마세우티컬스, 인코포레이티드 | 위장 운동 장애의 치료에 유용한 조성물 |
| KR20060099524A (ko) * | 2003-11-03 | 2006-09-19 | 아스트라제네카 아베 | 무증상 위식도 역류의 치료를 위한 이미다조[1,2-ａ]피리딘유도체 |
| US20070010543A1 (en) * | 2005-07-01 | 2007-01-11 | Dynogen Pharmaceuticals, Inc. | Compositions and methods for treating gastrointestinal hypomotility and associated disorders |
| WO2008011016A2 (en) * | 2006-07-18 | 2008-01-24 | Dynogen Pharmaceuticals, Inc. | Treating gastroesophageal reflux disease with 5-ht3- and gaba receptor agonists |
| CA2690581A1 (en) * | 2007-06-07 | 2008-12-18 | Dynogen Pharmaceuticals, Inc. | Compositions useful for treating gastroesophageal reflux disease |
| KR101605063B1 (ko) * | 2009-07-09 | 2016-03-21 | 라퀄리아 파마 인코포레이티드 | 소화관 운동이상이 관여하는 질환의 치료용 산 펌프 길항제 |
| BR112013020641B1 (pt) * | 2011-02-25 | 2021-11-03 | Yuhan Corporation | Composto, composição farmacêutica, processos para a preparação de composto e respectivo uso ou de seu sal farmaceuticamente aceitável |
| WO2020185857A1 (en) * | 2019-03-12 | 2020-09-17 | The Board Of Regents Of The University Of Texas System | Simultaneous blood glucose monitoring and gastric emptying scintigraphy |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0220011A3 (en) * | 1985-10-12 | 1990-01-03 | Beecham Group Plc | Use of azabicloalkylbenzamides in the treatment of gastrointestinal motility disorders, migraine, emesis, cluster headaches, trigeminal neuralgia and arrhythmia |
| GB8630079D0 (en) * | 1986-12-17 | 1987-01-28 | Glaxo Group Ltd | Medicaments |
| IE903747A1 (en) * | 1989-10-19 | 1991-04-24 | Searle & Co | Method of treating gastrointestinal motility disorders |
| US5260303A (en) * | 1991-03-07 | 1993-11-09 | G. D. Searle & Co. | Imidazopyridines as serotonergic 5-HT3 antagonists |
| JP2699794B2 (ja) * | 1992-03-12 | 1998-01-19 | 三菱化学株式会社 | チエノ〔３，２−ｂ〕ピリジン誘導体 |
| SE9600072D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
| ES2109190B1 (es) * | 1996-03-22 | 1998-07-01 | Univ Madrid Complutense | Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht |
| US6288234B1 (en) * | 1998-06-08 | 2001-09-11 | Advanced Medicine, Inc. | Multibinding inhibitors of microsomal triglyceride transferase protein |
| TR200100431T2 (tr) * | 1998-08-10 | 2001-06-21 | Partnership Of Michael E. Garst, George Sachs & Jai Moo | Proton pompalama önleyici ilaçlar |
| US6436953B1 (en) * | 1998-09-23 | 2002-08-20 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tetrahydropyridoethers |
| US6362202B1 (en) * | 1999-03-02 | 2002-03-26 | Sepracor Inc. | Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| US6353005B1 (en) * | 1999-03-02 | 2002-03-05 | Sepracor, Inc. | Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist |
| JP3354132B2 (ja) * | 1999-06-15 | 2002-12-09 | 三共株式会社 | 光学活性なピロロピリダジン化合物 |
| TWI256314B (en) * | 2000-02-09 | 2006-06-11 | Mitsubishi Pharma Corp | Preventive-therapeutical medicament for gastroesophageal reflux disease |
| JP4584534B2 (ja) * | 2000-06-07 | 2010-11-24 | アリックス セラピューティクス | 胃食道逆流性疾患の治療のための材料 |
| JP2004518709A (ja) * | 2001-02-13 | 2004-06-24 | アストラゼネカ・アクチエボラーグ | 新規放出修飾製剤 |
| SE0101379D0 (sv) * | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
| MXPA03011096A (es) * | 2001-05-29 | 2004-12-06 | Depomed Dev Ltd | Metodo para el tratamiento de la enfermedad de reflujo gastroesofagico y la saturacion acida nocturna. |
| EP1829543B1 (en) * | 2001-08-24 | 2009-01-21 | Mitsubishi Tanabe Pharma Corporation | Preventive agent/remedial agent for constipation predominant IBS |
| US20060281682A1 (en) * | 2003-01-28 | 2006-12-14 | Currie Mark G | Methods and compositions for the treatment of gastrointestinal disorders |
| WO2004105795A1 (en) * | 2003-05-27 | 2004-12-09 | Altana Pharma Ag | Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility |
| KR20060118421A (ko) * | 2003-08-29 | 2006-11-23 | 다이노젠 파마세우티컬스, 인코포레이티드 | 위장 운동 장애의 치료에 유용한 조성물 |
-
2004
- 2004-08-27 KR KR1020067004207A patent/KR20060118421A/ko not_active Withdrawn
- 2004-08-27 EP EP04782565A patent/EP1663313A2/en not_active Withdrawn
- 2004-08-27 AU AU2004268641A patent/AU2004268641A1/en not_active Abandoned
- 2004-08-27 US US10/928,624 patent/US20050059704A1/en not_active Abandoned
- 2004-08-27 MX MXPA06002139A patent/MXPA06002139A/es not_active Application Discontinuation
- 2004-08-27 JP JP2006524933A patent/JP2007507425A/ja active Pending
- 2004-08-27 WO PCT/US2004/028115 patent/WO2005021040A2/en not_active Ceased
- 2004-08-27 BR BRPI0414046-0A patent/BRPI0414046A/pt not_active IP Right Cessation
- 2004-08-27 CA CA002537182A patent/CA2537182A1/en not_active Abandoned
-
2006
- 2006-02-20 IL IL173835A patent/IL173835A0/en unknown
- 2006-04-28 US US11/413,857 patent/US20060189648A1/en not_active Abandoned
-
2008
- 2008-10-20 US US12/288,390 patent/US20090048287A1/en not_active Abandoned
-
2009
- 2009-11-11 AU AU2009236019A patent/AU2009236019B9/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005021040A3 (en) | 2008-01-03 |
| AU2009236019A1 (en) | 2009-12-03 |
| JP2007507425A (ja) | 2007-03-29 |
| BRPI0414046A (pt) | 2006-10-24 |
| AU2009236019B2 (en) | 2011-07-07 |
| CA2537182A1 (en) | 2005-03-10 |
| US20090048287A1 (en) | 2009-02-19 |
| AU2004268641A1 (en) | 2005-03-10 |
| MXPA06002139A (es) | 2006-05-31 |
| WO2005021040A2 (en) | 2005-03-10 |
| AU2009236019B9 (en) | 2011-08-25 |
| US20050059704A1 (en) | 2005-03-17 |
| US20060189648A1 (en) | 2006-08-24 |
| KR20060118421A (ko) | 2006-11-23 |
| EP1663313A2 (en) | 2006-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0314210D0 (en) | Laundry treatment compositions | |
| GB0314211D0 (en) | Laundry treatment compositions | |
| PL1794275T3 (pl) | Kompozycje przeznaczone do obróbki praniem | |
| PL1794276T3 (pl) | Kompozycje do obróbki bielizny do prania | |
| GB0421145D0 (en) | Laundry treatment compositions | |
| GB0420203D0 (en) | Laundry treatment compositions | |
| PL1644021T3 (pl) | Sposoby i kompozycje do leczenia zaburzeń żołądkowo-jelitowych | |
| ZA200704091B (en) | Laundry treatment compositions | |
| GB0329907D0 (en) | Compositions | |
| GB0411995D0 (en) | Laundry treatment compositions | |
| IL173835A0 (en) | Compositions useful for treating gastrointestinal motility disorders | |
| EP1613352A4 (en) | MICRO-AGREED COMPOSITIONS | |
| GB0313900D0 (en) | Laundry treatment compositions | |
| GB0329597D0 (en) | Compositions | |
| GB0300602D0 (en) | Compositions | |
| GB2426705B (en) | Herbal composition for gastrointestinal disorders | |
| GB0230026D0 (en) | Laundry treatment compositions | |
| GB0324574D0 (en) | Novel compositions | |
| GB0328023D0 (en) | Novel compositions | |
| GB0316857D0 (en) | Compositions | |
| ZA200506880B (en) | Hydrofluorocarbon compositions | |
| GB0325619D0 (en) | Laundry treatment compositions | |
| GB0314836D0 (en) | Novel compositions | |
| GB0300374D0 (en) | Organoclay compositions | |
| GB0325537D0 (en) | Compositions |